Please ensure Javascript is enabled for purposes of website accessibility
SC Biz News
Advertisement

Manufacturing

DuPont opening new production facility at Lowcountry plant

Manufacturing
  • Share

DuPont has opened a new manufacturing facility in Berkeley County. (Photo/Provided)

Wilmington, Del.-headquartered DuPont has opened a new manufacturing facility at its Berkeley County plant that will have a global reach.

The Liveo Healthcare facility, located at DuPont’s Cooper River plant, will increase the company’s biopharmaceutical production capacity and expand its worldwide customer base, according to a DuPont news release.

DuPont Liveo Healthcare is a silicone-based technology for a range of innovations in medical devices, biopharmaceutical processing and pharmaceutical solutions.

“The biopharma processing manufacturing investment at Cooper River is a key milestone in our growth strategy; it supports our customers’ expansion and contributes to business continuity,” Eugenio Toccalino, DuPont Healthcare & Specialty Lubricants Global Business director, said in the release. “We’re committed to investing in our healthcare business, and our recent expansions help us offer a highly reliable and sustainable product supply.”

In the second half of 2022, the company expects to add biopharma silicone tubing capacity in China, according to the release.

The new Cooper River facility was completed in 18 months and created 25 jobs, the release said, with an additional 25 jobs expected to be created in the next two years.  

“For more than 14 years, DuPont Cooper River has continued to diversify and reinvest in new products ensuring the viability of this Berkeley County facility,” Kristen Lanier, Berkeley County Economic Development director, said in the release. “Life sciences and biotechnology innovation is a growing sector with an $11 billion annual economic impact and over 40,000 jobs in the State of South Carolina.”

In 2021, DuPont’s Cooper River site expanded to include manufacturing of specialty lubricants.

DuPont declined to reveal investment costs or major contractors for the new facility.

The company, which trades as DD on the New York Stock Exchange, reported 2021 revenue of $16.7 billion, down from $20.4 billion in 2020.

Reach Melinda Waldrop at 803-726-7542.

  • Share
0 Comments
Write a Comment

Subscribe to Our Digital Newsletters